Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.16B | 1.27B | 1.27B | 1.23B | 1.20B |
| Total Depreciation and Amortization | 1.01B | 1.00B | 998.00M | 987.50M | 977.00M |
| Total Amortization of Deferred Charges | 59.00M | 60.00M | 60.00M | 58.50M | 57.00M |
| Total Other Non-Cash Items | 298.00M | 294.00M | 322.00M | 266.00M | 210.00M |
| Change in Net Operating Assets | -783.00M | -1.18B | -1.12B | -897.50M | -675.00M |
| Cash from Operations | 1.74B | 1.44B | 1.53B | 1.65B | 1.77B |
| Capital Expenditure | -480.00M | -433.00M | -439.00M | -401.50M | -364.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 6.00M | 0.00 | -890.00M | -1.01B | -1.13B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -1.00M | -2.00M | -3.00M |
| Cash from Investing | -474.00M | -433.00M | -1.33B | -1.41B | -1.49B |
| Total Debt Issued | 7.75B | 14.04B | 8.65B | 12.37B | 16.10B |
| Total Debt Repaid | -11.88B | -14.10B | -9.20B | -12.68B | -16.16B |
| Issuance of Common Stock | 7.05B | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.00B | -34.00M | -19.00M | -19.50M | -20.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -518.00M | -1.78B | -1.70B | -1.61B | -1.52B |
| Other Financing Activities | -- | -8.00M | -11.00M | -11.50M | -12.00M |
| Cash from Financing | 399.00M | -1.89B | -2.29B | -1.95B | -1.61B |
| Foreign Exchange rate Adjustments | 23.00M | 22.00M | 23.00M | 12.50M | 2.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.69B | -861.00M | -2.07B | -1.70B | -1.34B |